Scleroderma, Systemic: Clinical Trials

1 trial for Scleroderma, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Suspended 1

Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
anti-CD19 CAR-T cells - Systemic Sclerosis (SSc)
Phase 1SuspendedThe Children's Hospital of Zhejiang University School of Medicine122025-12-142026-09-08

Broader conditions

Connective Tissue Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

The Children's Hospital of Zhejiang University School of Medicine (1)

Countries

China (1)  ·  Christmas Island (1)